Drive growth through portfolio development and commercialisation Cross-functional portfolio leadership in how CSL sources, discovers, develops and drives demand for life-changing medicines Create value through operational excellence, productivity and scale Operational excellence across the network, end-to-end plasma leadership and accelerating enterprise initiatives to unlock value Enable our people and partners to deliver the Company’s future Agile & empowered employees living CSL’s Values, hand-in-hand with trusted partners, supported by business-focused enabling functions and transformative digital capabilities OUR AMBITIONS THERAPEUTIC AREAS Patients Who need durable, effective treatment for, and protection from serious disease Diseases Where CSL has a fundamental advantage in understanding the disease and science Medicines With a high degree of specialist expertise of manufacturing differentiation + R EAD MORE ABOUT OUR THERAPEUTIC AREAS ON PAGE 14 Immunoglobulins Vaccines Cardiovascular and Renal Immunology Haematology OUR FOCUS 9 CSL Limited Annual Report 2025/26
RkJQdWJsaXNoZXIy MjE2NDg3